Hantgo.com

Stay Informed Stay Ahead

    • Medicine

    Global Confidence in Drug Delivery Innovation Remains at Record Highs Say Pharmapack

    admin Posted on

    The annual Pharmapack Drug Delivery Innovation Index is released ahead of Europe’s premier drug delivery and packaging event, Pharmapack Europe 2024. The results showed a slight increase on the record scores seen in the 2023 survey, indicative of a continued resurgence in confidence and innovation across pharma R&D.

    The Index [scored out of ten] is a collateralised metric of drug delivery and device innovation across the major pharma nations. Significantly for industry prospects in 2024, the index rose very slightly to 7.45 up from a previous record score 7.44 in 2023. With the majority of countries maintaining or seeing slight falls in year-on-year scores, France was easily the Index’s biggest mover (+11%) rising to fourth in the rankings with Germany supplanting its perennial rival, the USA, to lead the rankings in 2024.

    The results of the Pharmapack Index are widely seen as a key measure of industry confidence for the year ahead and point to renewed device innovation in 2024 – with all European nations preforming strongly.

    Emphasising the shift, more than 5,000 attendees and over 370 companies are expected at Pharmapack Europe, with the event seeing a notable rise in early stage companies attending during the last year – with its Start-Up Hub now boasting over 20 companies. In fact, the event is widely seen as hotbed of future innovation and will host the eponymous Pharmapack Awards, Learning Labs and Innovation Tours – all of which are designed to showcase promising technologies and empower greater collaborative development.

    “After a record attendance at CPHI Barcelona, the Pharmapack Index – which is a measure of drug delivery R&D confidence – has retained its record strength and there is a great deal of excitement again for partnering, investing and commercialising promising device and packaging innovations. We are already anticipating a record event and most importantly an industry wide resurgence of partnering and novel device development throughout 2024,” commented Laura Indriksone, Brand Manager at Pharmapack Europe.

    In a further boon, two Country Pavilions will be launched for Switzerland and this year’s Index star performer, France. The Pavilions were launched in response to high demand.  

    The top three countries from last year (Germany, USA, and the UK) all maintained their positions with very similar scores, but both France and Italy improved and have now replaced China and India within the top five. The results emphasise an emerging European domination of drug device and packaging innovation, boasting four of the top five nations, and with a European country narrowly supplementing the USA to lead the rankings for the first time.

    “Pharmapack is a reflection of the industry and Europe is now collectively the hub of global device and packing innovation. We have designed this year’s event to help harness industry potential, not only for the devices and packaging that will lead the market in 2024, but also so that the industry can learn, share and discover innovations that might move the market over the medium term. With R&D taking many years to complete it’s incredibly important that the community comes together to help accelerate this progress. All across the sector we are seeing a studious and holistic approach to product development – with the industry focussed on real world impacts and life cycle approaches. The passion and dedication to innovation is what makes this show so rewarding to deliver,” added Indriksone

    The agenda at Pharmapack will also address many of the current ‘hotbed’ issues in development including the challenges associated with high-volume drugs, high-viscosity medications and how to optimise patient-centric solutions. Moreover, sessions will also explore the rise of prefilled syringes, automatic delivery devices and the evolution of sustainable packaging solutions. In fact, this fusion of innovation is giving rise to packaging innovations designed not only to elevate user experience, but also, contribute to environmental sustainability.

    The full results of the Pharmapack Report 2024 and Index will be released during the event on  CPHI-online. Click here for a full breakdown of conference topics, or more information on the event please visit: www.pharmapackeurope.com/en

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Medicine

    Aramex Scoop Sustainability AwardGlobal logistics giant Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very best in innovation and sustainability from those that are directly involved in the design, development or distribution of pharmaceuticals – a sector in which Aramex has a significant footprint. Despite being up against fierce competition within their selected category, the judges ruled that Aramex’s unwavering commitment to sustainability, environmental stewardship, and mitigating climate risks were what tipped the scales on the night. Citing a 42% reduction based on scope 1 & 2 and a 25% reduction on scope 3, dependent on supplier commitment, Aramex has since 2006 implemented a multifaceted climate change mitigation strategy with the sole aim of minimising its carbon footprint and improving its impact on the environment. This strategy involves investment into renewable energy projects, commitment to minimising waste and promoting recycling across its network, enhancing energy efficiency across its operations, with initiatives such as ISO 14001 certification, LEED certification for its facilities along with further energy efficiency projects to drive down usage. Reduced water consumption, route optimisation projects to reduce fuel consumption and emissions, and a commitment to gradually transitioning its fleet to electric and low-emission vehicles have also been put in place. Aramex has also implemented its Future Vehicle Program which explores innovative solutions such as autonomous vehicles and drone deliveries to enhance efficiency and reduce environmental impact in the years to come. Ronan Kitchin who heads up the Life Science and Healthcare division at Aramex UK commented: “We are delighted to have been recognised by Distributing Pharmaceuticals at their recent award event for our work in driving sustainability initiatives throughout our distribution services – a commitment which we have made significant strides towards over the past two decades. “With a legacy of championing sustainability, our environmental and climate change mitigation strategy looks to deliver tangible and positive changes in reducing emissions across the entire business – whether that be in our efforts to minimise waste or reducing fuel consumption. Ensuring our footprint is kept at a minimum where possible is at the top of our agenda and we couldn’t be prouder that this has been recognised by an independent panel of respected industry experts within the pharmaceutical industry – a sector within which we have a long and proud history serving. “Ultimately, it’s about doing the right thing. The world is undergoing a rate of change which is incomparable to anything humankind has ever faced before and therefore all need to play their part if the collective goal of defeating the worsening climate crisis is to be achieved. A huge thanks must therefore go out to all team members across the Aramex network who have each played a part in helping the company make such incredible inroads in its own sustainability goals.”

    admin
    Slot gacor maxwin
    Slot88
    TOGEL ONLINE